OR WAIT null SECS
Angie Drakulich was editorial director of Pharmaceutical Technology.
November 08, 2007
King Pharmaceuticals, and Acura Pharmaceuticals have entered into a license, development and commercialization agreement for the United States, Canada, and Mexico, encompassing a potentially wide range of opioid analgesic products utilizing Acura?s patented Aversion (abuse-deterrent) Technology platform.
November 02, 2007
As the mother of a 15-month-old, I was quite shaken last month to hear about over-the-counter cold medicines for children under age 2 being pulled off the shelves. Glued to the news, I wondered if the decongestant I had given my daughter when she was sick would have any negative impact on her long-term health.
November 01, 2007
The pharmaceutical market is undergoing a major transformation with companies moving more and more toward the generics business, according to a new report.
October 24, 2007
After a whirlwind of negative press this fall regarding the safety of cough and cold medications for children under age 6, the US Food and Drug Administration?s Nonprescription Drugs and Pediatric Advisory Committees have recommended such over-the-counter drugs no longer be used for young children.
October 11, 2007
The US Food and Drug Administration launched a new program to increase the number and variety of generic drugs available to the public, beginning in FY2008.
October 05, 2007
Cardinal Health began construction on a $50 million expansion of its headquarters in Dublin, Ohio, on Oct. 3, 2007.